Silvana Martino

10.2k total citations
72 papers, 4.6k citations indexed

About

Silvana Martino is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Silvana Martino has authored 72 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 17 papers in Immunology and 16 papers in Cancer Research. Recurrent topics in Silvana Martino's work include Breast Cancer Treatment Studies (11 papers), Cancer Treatment and Pharmacology (9 papers) and HER2/EGFR in Cancer Research (8 papers). Silvana Martino is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Cancer Treatment and Pharmacology (9 papers) and HER2/EGFR in Cancer Research (8 papers). Silvana Martino collaborates with scholars based in Italy, United States and Belarus. Silvana Martino's co-authors include C. Kent Osborne, Richard Elledge, Michael D. Lagios, Susan Groshen, James Waisman, Melvin J. Silverstein, Bernard S. Lewinsky, Parvis Gamagami, William J. Colburn and Stephanie Green and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Silvana Martino

71 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvana Martino Italy 31 1.6k 1.2k 1.2k 834 781 72 4.6k
Marek Z. Wojtukiewicz Poland 34 2.2k 1.3× 592 0.5× 939 0.8× 301 0.4× 1.0k 1.3× 190 4.5k
Katsumasa Kuroi Japan 32 2.2k 1.3× 509 0.4× 1.3k 1.1× 268 0.3× 869 1.1× 143 3.8k
Jacintha O’Sullivan Ireland 41 1.7k 1.0× 942 0.8× 1.2k 1.0× 272 0.3× 2.2k 2.8× 171 5.3k
Adnan Munkarah United States 41 1.5k 1.0× 954 0.8× 1.1k 0.9× 450 0.5× 1.9k 2.5× 182 6.2k
Nicolaì Maass Germany 33 1.8k 1.1× 416 0.4× 1.1k 0.9× 441 0.5× 1.3k 1.7× 274 4.9k
Prudence A. Francis Australia 34 3.3k 2.0× 632 0.5× 1.5k 1.3× 562 0.7× 890 1.1× 129 5.1k
Roy B. Jones United States 43 2.5k 1.5× 791 0.7× 770 0.7× 448 0.5× 970 1.2× 176 6.6k
Sumio Kawata Japan 45 984 0.6× 492 0.4× 555 0.5× 424 0.5× 1.8k 2.3× 181 6.1k
Klaas Hoekman Netherlands 41 2.4k 1.5× 470 0.4× 983 0.9× 226 0.3× 1.9k 2.5× 102 5.2k
Sun‐Young Kong South Korea 32 1.3k 0.8× 373 0.3× 683 0.6× 310 0.4× 1.4k 1.8× 204 3.7k

Countries citing papers authored by Silvana Martino

Since Specialization
Citations

This map shows the geographic impact of Silvana Martino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvana Martino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvana Martino more than expected).

Fields of papers citing papers by Silvana Martino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvana Martino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvana Martino. The network helps show where Silvana Martino may publish in the future.

Co-authorship network of co-authors of Silvana Martino

This figure shows the co-authorship network connecting the top 25 collaborators of Silvana Martino. A scholar is included among the top collaborators of Silvana Martino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvana Martino. Silvana Martino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geraldo, Ana Filipa, Roberta Caorsi, Domenico Tortora, et al.. (2021). Widening the Neuroimaging Features of Adenosine Deaminase 2 Deficiency. American Journal of Neuroradiology. 42(5). 975–979. 13 indexed citations
2.
Ferrara, Giovanna, Greta Mastrangelo, Patrizia Barone, et al.. (2018). Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. Pediatric Rheumatology. 16(1). 46–46. 83 indexed citations
3.
Coppo, Rosanna, Licia Peruzzi, Alessandro Amore, et al.. (2014). Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy. Pediatric Nephrology. 30(1). 167–172. 60 indexed citations
4.
Cirillo, Emilia, Giuliana Giardino, Vera Gallo, et al.. (2014). Intergenerational and intrafamilial phenotypic variability in 22q11.2 Deletion syndrome subjects. BMC Medical Genetics. 15(1). 1–1. 84 indexed citations
5.
Violi, Francesco, Valerio Sanguigni, Roberto Carnevale, et al.. (2009). Hereditary Deficiency of gp91 phox Is Associated With Enhanced Arterial Dilatation. Circulation. 120(16). 1616–1622. 109 indexed citations
6.
Hershman, Dawn L., Joseph M. Unger, William E. Barlow, et al.. (2009). Treatment Quality and Outcomes of African American Versus White Breast Cancer Patients: Retrospective Analysis of Southwest Oncology Studies S8814/S8897. Journal of Clinical Oncology. 27(13). 2157–2162. 99 indexed citations
7.
Marangoni, Francesco, Sara Trifari, Samantha Scaramuzza, et al.. (2007). WASP regulates suppressor activity of human and murine CD4+CD25+FOXP3+ natural regulatory T cells. The Journal of Experimental Medicine. 204(2). 369–380. 137 indexed citations
8.
Roche, Patrick C., VJ Suman, Robert B. Jenkins, et al.. (2002). Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831. JNCI Journal of the National Cancer Institute. 94(11). 855–857. 313 indexed citations
9.
Martino, Silvana, et al.. (2000). Treatment of Hepatic Abscesses in Chronic Granulomatous Disease with Granulocyte-Macrophage Colony-Stimulating Factor. Clinical Infectious Diseases. 30(1). 222–223. 6 indexed citations
10.
Ellis, Georgiana K., Stephanie Green, Robert B. Livingston, et al.. (1999). ‘Neo-FAC’ (5-Fluorouracil, Doxorubicin, and Cyclophosphamide) for Poor-Prognosis Stage IV Breast Cancer. American Journal of Clinical Oncology. 22(5). 446–446. 1 indexed citations
11.
Silverstein, Melvin J., Michael D. Lagios, Susan Groshen, et al.. (1999). The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the Breast. New England Journal of Medicine. 340(19). 1455–1461. 470 indexed citations
12.
Elledge, Richard, Daniel R. Ciocca, R Pugh, et al.. (1998). HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.. PubMed. 4(1). 7–12. 203 indexed citations
13.
Green, Stephanie, et al.. (1998). Expanded phase II trial of paclitaxel in metastatic breast cancer: A Southwest Oncology Group study. Breast Cancer Research and Treatment. 51(2). 169–181. 11 indexed citations
14.
Djurić, Zora, et al.. (1998). Oxidative DNA Damage Levels in Blood from Women at High Risk for Breast Cancer are Associated with Dietary intakes of Meats, Vegetables, and Fruits. Journal of the American Dietetic Association. 98(5). 524–528. 47 indexed citations
15.
Simon, Michael S., et al.. (1997). A randomized trial of a low‐fat dietary intervention in women at high risk for breast cancer. Nutrition and Cancer. 27(2). 136–142. 44 indexed citations
16.
17.
Bigler, Mike, et al.. (1996). Immune Functions of Cord Blood Cells before and after Transplantation. Journal of Hematotherapy. 5(2). 157–160. 16 indexed citations
18.
Ravdin, Peter M., Stephanie Green, James H. Doroshow, & Silvana Martino. (1994). Phase II trial of piroxantrone in metastatic breast cancer. Investigational New Drugs. 12(4). 333–336. 4 indexed citations
19.
Simon, Michael S., et al.. (1993). An evaluation of clinical follow-up in women with early stage breast cancer among physician members of the American Society of Clinical Oncology. Breast Cancer Research and Treatment. 27(3). 211–219. 9 indexed citations
20.
Flaherty, Lawrence E., Antoinette J. Wozniak, Bruce G. Redman, et al.. (1991). 5-fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer. Cancer. 68(5). 944–947. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marek Z. Wojtukiewicz Breakdown of academic impact, for papers by Katsumasa Kuroi Breakdown of academic impact, for papers by Jacintha O’Sullivan Breakdown of academic impact, for papers by Adnan Munkarah Breakdown of academic impact, for papers by Nicolaì Maass Breakdown of academic impact, for papers by Prudence A. Francis Breakdown of academic impact, for papers by Roy B. Jones Breakdown of academic impact, for papers by Sumio Kawata Breakdown of academic impact, for papers by Klaas Hoekman Breakdown of academic impact, for papers by Sun‐Young Kong
Rankless by CCL
2026